Filing Details
- Accession Number:
- 0001213900-21-063945
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2021-12-07 16:30:31
- Reporting Period:
- 2021-08-09
- Accepted Time:
- 2021-12-07 16:30:31
- Original Submission Date:
- 2021-08-11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1176309 | Oramed Pharmaceuticals Inc. | ORMP | Pharmaceutical Preparations (2834) | 980376008 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1351779 | Nadav Kidron | 1185 Avenue Of The Americas, Third Floor New York, NY 10036 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-08-09 | 220,000 | $20.11 | 738,209 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 18, 2021.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 18, 2021.
- This amendment is being filed to correct an administrative error in Form 4 filed by Mr. Kidron, which reported that 648,573 shares of common stock are beneficially owned by him following the reported transaction. Mr. Kidron beneficially owned 738,209 shares of common stock following the reported transaction.
Billionaire Hedge Funds
